NCT05599412
- Conditions
- Metastatic ALK+ Non Small Cell Lung Cancer
- Locations
-
- Pfizer Seoul, South Korea
Clinical trial condition
Metastatic ALK+ Non Small Cell Lung Cancer
Explore clinical trials studying Metastatic ALK+ Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study